Biosenta Inc.
ZRO
CNSX
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 100.00 | 300.00 | 100.00 | 100.00 | 200.00 |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 100.00 | 300.00 | 100.00 | 100.00 | 200.00 |
| Cost of Revenue | 100.00 | 200.00 | 2.60K | 100.00 | 100.00 |
| Gross Profit | 100.00 | 100.00 | -2.50K | 0.00 | 100.00 |
| SG&A Expenses | 181.40K | 265.20K | 357.90K | 244.60K | 180.90K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 182.30K | 299.80K | 367.00K | 251.10K | 183.30K |
| Operating Income | -182.20K | -299.50K | -366.80K | -251.00K | -183.10K |
| Income Before Tax | -346.30K | -3.90M | -368.10K | -249.00K | -178.20K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -346.30K | -3.90M | -368.10K | -249.00K | -178.20K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -346.30K | -3.90M | -368.10K | -249.00K | -178.20K |
| EBIT | -182.20K | -299.50K | -366.80K | -251.00K | -183.10K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.01 | -0.11 | -0.02 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| EPS Diluted | -0.01 | -0.11 | -0.02 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | 0.00 |
| Average Basic Shares Outstanding | 26.46M | 35.41M | 23.06M | 23.01M | 23.01M |
| Average Diluted Shares Outstanding | 26.46M | 35.41M | 23.06M | 23.01M | 23.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
